Related Experiment Video
Updated: Jun 8, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Deciphering the roles of cellular and extracellular non-coding RNAs in chemotherapy-induced cardiotoxicity
Pan Feng1, Fan Yang2, Dongmei Zang3
1Baoji Hospital of Traditional Chinese Medicine, Baoji, 721000, China.
Abstract:
Chemotherapy-induced cardiotoxicity is a major adverse effect, driven by multiple factors in its pathogenesis. Notably, RNAs have emerged as significant contributors in both cancer and heart failure (HF). RNAs carry genetic and metabolic information that mirrors the current state of cells, making them valuable as potential biomarkers and therapeutic tools for diagnosing, predicting, and treating a range of diseases, including cardiotoxicity. Over 97% of the genome is transcribed into non-coding RNAs (ncRNAs), including ribosomal RNA (rRNAs), transfer RNAs (tRNAs), and newly identified microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs). NcRNAs function not only within their originating cells but also in recipient cells by being transported through extracellular compartments, referred to as extracellular RNAs (exRNAs). Since ncRNAs were identified as key regulators of gene expression, numerous studies have highlighted their significance in both cancer and cardiovascular diseases. Nevertheless, the role of ncRNAs in cardiotoxicity remains not fully elucidated. The study aims to review the existing knowledge on ncRNAs in Cardio-Oncology and explore the potential of ncRNA-based biomarkers and therapies. These investigations could advance the clinical application of ncRNA research, improving early detection and mitigating of chemotherapy-induced cardiotoxicity.
Insights
Non-coding RNAs (ncRNAs) play a role in chemotherapy-induced cardiotoxicity. This review explores ncRNAs as potential biomarkers and therapies for early detection and mitigation of heart damage.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Chemotherapy-induced cardiotoxicity is a significant clinical challenge.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in both cancer and cardiovascular diseases.
- The specific involvement of ncRNAs in cardiotoxicity requires further elucidation.
Purpose of the Study:
- To review current knowledge on ncRNAs in Cardio-Oncology.
- To explore the potential of ncRNAs as biomarkers for diagnosing and predicting cardiotoxicity.
- To investigate ncRNA-based therapeutic strategies for mitigating chemotherapy-induced heart damage.
Main Methods:
- Literature review of studies on ncRNAs in cancer and cardiovascular diseases.
- Analysis of the role of various ncRNA types (miRNAs, lncRNAs, circRNAs) in cardiotoxicity.
- Exploration of extracellular RNAs (exRNAs) as potential mediators.
Main Results:
- ncRNAs are crucial regulators of gene expression with implications in cellular states.
- Over 97% of the genome is transcribed into diverse ncRNAs.
- ncRNAs can function both intracellularly and extracellularly, influencing recipient cells.
Conclusions:
- ncRNAs hold significant promise as biomarkers for early detection of cardiotoxicity.
- ncRNA-based therapies could offer novel strategies for preventing or treating chemotherapy-induced heart damage.
- Further research into ncRNAs in Cardio-Oncology can advance clinical applications and patient outcomes.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Experimental RNAi
MicroRNAs
Heart Failure Drugs: Inotropic Agents

